338 filings
Page 14 of 17
8-K
fqibln
6 Oct 14
Sorrento and Lee’s Pharmaceutical Enter into Exclusive China Licensing Agreement to Develop and CommercializeAnti-PD-L1 antibody
12:00am
8-K
mwd4oc0u4ly3lyb
21 Aug 14
Departure of Directors or Certain Officers
12:00am
8-K
tqju t0yno9
18 Aug 14
Other Events
12:00am
8-K
rqh3c76ft
8 Aug 14
Sorrento Therapeutics Appoints Douglas Ebersole to its Board of Directors
12:00am
8-K
2dnfd8k8k1vt
31 Jul 14
Sorrento Announces the Unexpected Death of its Chief Business Officer
12:00am
8-K
cwjzrtyx 5p71plx
21 Jul 14
Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor
12:00am
8-K
gpjqig wh08
1 Jul 14
Other Events
12:00am
8-K
pdcs2tbpg
25 Jun 14
Morphotek and Sorrento Therapeutics Sign an Exclusive Research and Option Agreement to generate and develop Morphotek Antibody Drug Conjugates
12:00am
8-K
j80un8e
23 Jun 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
46yvtq6a 3axjbfv
3 Jun 14
Regulation FD Disclosure
12:00am
8-K
ue6bz
30 May 14
Sorrento Therapeutics to Present at Jefferies 2014 Global Healthcare Conference
12:00am
8-K
io2orzz2he8 gruw1y9
15 May 14
Sorrento Therapeutics, Inc. Announces Pricing of Public Offering of
12:00am
8-K
wt08 1u8t0wti9b1d
13 May 14
Sorrento Announces Transfer of Orphan Drug Designation Sponsorship for Intrathecal Resiniferatoxin from NIH
12:00am
8-K
8rs2h0o1m 5cbl78k
4 Apr 14
Sorrento Announces Presentation of Data from Clinical Study of
12:00am
8-K
3zzdt0
1 Apr 14
Sorrento Announces First Patient Dosed in Registration Trial to
12:00am
8-K
rsv4k0b
25 Mar 14
Resiniferatoxin for Treatment of Pain Associated with Osteosarcoma Veterinary Program Expected to File for MUMS designation in 2014
12:00am
8-K
ifi8 7k8d2npfej
20 Mar 14
Regulation FD Disclosure
12:00am
8-K
p2ae3mi4sdfzb646jia2
11 Mar 14
Sorrento Therapeutics Appoints Mark Durand to its Board of Directors
12:00am
8-K/A
u34jfw az
3 Mar 14
Financial Statements and Exhibits
12:00am
8-K
3ls4v tgr1x2ghd0vf
3 Feb 14
Sorrento Therapeutics Welcomes Daniel Levitt as a Director to its Board
12:00am